BiotechTube

YM178 modified release (OCAS) + YM178 immediate release (IR)

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pharmacokinetics of YM178

Conditions

Pharmacokinetics of YM178, Healthy Subjects

Trial Timeline

Jan 1, 2005 → May 1, 2005

NCT ID
NCT01646294

About YM178 modified release (OCAS) + YM178 immediate release (IR)

YM178 modified release (OCAS) + YM178 immediate release (IR) is a phase 1 stage product being developed by Astellas Pharma for Pharmacokinetics of YM178. The current trial status is completed. This product is registered under clinical trial identifier NCT01646294. Target conditions include Pharmacokinetics of YM178, Healthy Subjects.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01646294Phase 1Completed

Competing Products

20 competing products in Pharmacokinetics of YM178

See all competitors
ProductCompanyStageHype Score
GP30341 capsules 200 mg + Standard therapyGEROPHARMPre-clinical
15
GP40221 + ozempicGEROPHARMPhase 1
25
Memantinol tablets, 20 mg + Akatinol Memantine® tablets, 20 mgGEROPHARMPhase 1
25
Rinsulin NPH + Humulin NPHGEROPHARMPre-clinical
15
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
33
DS-8500a + ItraconazoleDaiichi SankyoPhase 1
33
Milademetan + Itraconazole + PosaconazoleDaiichi SankyoPhase 1
33
Pexidartinib + ProbenecidDaiichi SankyoPhase 1
33
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
33
DS-8500aDaiichi SankyoPhase 1
33
Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment CDaiichi SankyoPhase 1
33
tolterodine + mirabegronAstellas PharmaApproved
85
ASP3652Astellas PharmaPhase 1
33
ASP015K ER + ASP015K IRAstellas PharmaPhase 1
33
Isavuconazole + dextromethorphanAstellas PharmaPhase 1
33
mirabegron + metoprololAstellas PharmaPhase 1
33
ASP015KAstellas PharmaPhase 1
33
zolbetuximab + oxaliplatin + leucovorin + fluorouracil + Pembrolizumab + folinic acid + nivolumab + DocetaxelAstellas PharmaPhase 2
52
Isavuconazole + Repaglinide + CaffeineAstellas PharmaPhase 1
33
mirabegron + rifampinAstellas PharmaPhase 1
33

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85